Activated α2-macroglobulin binding to cell surface GRP78 induces T-loop phosphorylation of Akt1 by PDK1 in

Uma Kant Misra1, Salvatore Vincent Pizzo1

  • 1Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America.

Plos One
|February 12, 2014
PubMed

Insights

Phosphoinositide-dependent kinase-1 (PDK1) requires Raptor, a protein in the mTORC1 complex, to phosphorylate Akt at Thr308. This scaffolding mechanism is crucial for signaling in prostate cancer cells.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • Phosphoinositide-dependent kinase-1 (PDK1) is a key kinase involved in cell signaling pathways.
  • PDK1 phosphorylates numerous substrates, including Akt, often through phosphoinositide triphosphate (PIP3)-dependent mechanisms.
  • Akt phosphorylation is critical for cell growth, survival, and metabolism, and its dysregulation is implicated in cancer.

Purpose of the Study:

  • To investigate the specific mechanism by which PDK1 phosphorylates Akt at the Thr308 residue in prostate cancer cells.
  • To determine the role of the mTORC1 complex, specifically Raptor, in mediating PDK1-Akt interactions.
  • To elucidate the signaling cascade initiated by activated α2-macroglobulin (α2M*) in prostate cancer cells.

Main Methods:

  • Co-immunoprecipitation assays to detect interactions between PDK1, Raptor, and mTOR.
  • RNA interference (RNAi) to silence the expression of PDK1 and Raptor.
  • Immunodepletion experiments to assess the necessity of Raptor and PDK1 for Akt phosphorylation.
  • Studies involving insulin receptor binding on prostate cancer cells.

Main Results:

  • PDK1, Raptor, and mTOR were shown to co-immunoprecipitate, indicating their presence within the same complex.
  • Silencing PDK1 or Raptor expression significantly reduced Akt phosphorylation at Thr308 in α2M*-stimulated prostate cancer cells.
  • Depletion of Raptor or PDK1 from cell lysates drastically decreased Akt phosphorylation, which could be restored by adding back the depleted components.

Conclusions:

  • Raptor, a component of the mTORC1 complex, acts as a scaffold protein for PDK1 to phosphorylate Akt at the Thr308 residue.
  • This PDK1-Raptor scaffolding mechanism is essential for Akt activation in response to α2M* stimulation in prostate cancer cells.
  • The findings reveal a novel regulatory mechanism for Akt phosphorylation, with implications for understanding prostate cancer progression and potential therapeutic targets.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K